Sirius Medtech

Sirius Medtech is a high-tech enterprise that integrates research and development, production, and sales in the field of heart failure and pulmonary interventional medical devices. The company currently has approximately 3,000 square meters of Class 10,000 clean production workshops and a 600-square-meter R&D center. It possesses complete R&D and production equipment, enabling an integrated independent production model from raw materials to finished products. Additionally, the company is equipped with advanced precision testing instruments such as shunt fatigue testers and high-performance gas chromatographs for strict detection and control of key product quality characteristics. All products in Sirius Medtech’s full series have complete independent intellectual property rights. The company owns more than 100 patents in the field of heart failure and pulmonary intervention, with technology levels ranking among the leading domestically and aligning with the most advanced global medical technologies for cardiopulmonary treatment. Based on a profound understanding of clinical needs, the founder and team of Sirius Medtech are committed to developing systematic solutions for heart failure and pulmonary diseases targeting different populations, needs, and scenarios. They have independently developed and established products such as cardiac high-pressure shunting technology, mitral stenosis dilation systems, ventricular volume reduction systems, automated cardiac informatics analysis platforms, pulmonary thrombus removal systems, and pulmonary hypertension volume reduction devices.